CD123 Redirected T Cells for AML in Pediatric Subjects

Clinical trial NCT04678336 · TERMINATED

Trial details

NCT number: NCT04678336
Sponsor: University of Pennsylvania
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia, Pediatric Acute Myeloid Leukemia, Refractory

Start date: 2021-04-02
Primary completion: 2025-05-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.